Company Filing History:
Years Active: 2015-2025
Title: Innovations by Thierry Eyrard in Hemodialysis Technology
Introduction
Thierry Eyrard is a notable inventor based in Lyons, France. He has made significant contributions to the field of medical technology, particularly in the area of hemodialysis. With a total of 8 patents to his name, Eyrard's work has had a profound impact on the efficiency and effectiveness of hemodialysis machines.
Latest Patents
One of Eyrard's latest patents is a method, facility, and tank for the manufacture of a liquid acid concentrate used for hemodialysis machines. This invention outlines a comprehensive process that includes several steps. Initially, a water source, an acid source, an electrolyte tank containing a precise mixture of electrolytes, and a sodium chloride source are connected to a mixing tank. The process begins with the introduction of the required quantity of water into the mixing tank. Following this, the necessary quantity of acid is added, and the solution is stirred until it becomes homogeneous. The method involves transferring parts of the solution between the mixing tank and the electrolyte tank to ensure complete dissolution of the electrolyte mixture. Finally, sodium chloride is introduced, and the solution is stirred and recirculated until a uniform liquid acid concentrate is achieved.
Career Highlights
Eyrard is currently employed at Fresenius Medical Care Deutschland GmbH, a leading company in the field of medical devices and services. His work at this organization has allowed him to focus on innovations that enhance patient care in hemodialysis.
Collaborations
Throughout his career, Eyrard has collaborated with several professionals, including Philippe Laffay and Benoit Luaire. These collaborations have contributed to the development of advanced technologies in the medical field.
Conclusion
Thierry Eyrard's contributions to hemodialysis technology through his innovative patents demonstrate his commitment to improving medical practices. His work continues to influence the industry and enhance patient outcomes.